Il y a eu 50 transactions d'initiés récentes enregistrées pour Alpine Immune Sciences, Inc. (ALPN), dont 13 achats et 37 ventes. Le total des achats d'initiés s'élève à $2.7M et le total des ventes d'initiés à $559.86M.
Les initiés notables ayant une activité récente comprennent Conway Robert E, Gold Mitchell, Topper James N. Les transactions d'initiés peuvent fournir des indications sur la façon dont la direction perçoit la valorisation et les perspectives futures de l'action.
Transactions d'Initiés — ALPN
| Date |
Nom |
Rôle |
Type de Transaction |
Actions |
Prix Moyen |
Valeur |
Actions détenues |
| 2024-05-20 |
Conway Robert E |
Director |
Restitution d'Actions |
17,500 |
$19.00 |
$332.5K |
- |
| 2024-05-20 |
Gold Mitchell |
Executive Chairman and CEO |
Restitution d'Actions |
240,000 |
$18.33 |
$4.4M |
- |
| 2024-05-20 |
Topper James N |
Director |
Restitution d'Actions |
17,500 |
$19.00 |
$332.5K |
- |
| 2024-05-20 |
Thompson Peter A. |
Director |
Restitution d'Actions |
17,500 |
$19.00 |
$332.5K |
- |
| 2024-05-20 |
Cui Xiangmin |
10 Percent Owner |
Restitution d'Actions |
17,500 |
$19.00 |
$332.5K |
- |
| 2024-05-20 |
Rickey James Paul |
See Remarks |
Restitution d'Actions |
78,000 |
$18.33 |
$1.43M |
- |
| 2024-05-20 |
Peetz Christopher |
Director |
Restitution d'Actions |
17,500 |
$19.00 |
$332.5K |
- |
| 2024-05-20 |
Peng Stanford L |
See Remarks |
Restitution d'Actions |
120,000 |
$18.33 |
$2.2M |
- |
| 2024-05-20 |
Hernday Natasha |
Director |
Restitution d'Actions |
17,500 |
$19.00 |
$332.5K |
- |
| 2024-05-20 |
Drappa Jorn |
Director |
Restitution d'Actions |
17,500 |
$19.00 |
$332.5K |
- |
| 2024-05-20 |
Durand Remy |
Chief Business Officer |
Restitution d'Actions |
78,000 |
$18.33 |
$1.43M |
- |
| 2024-05-20 |
Fuhs Ulrich Martin |
Chief Accounting Officer |
Restitution d'Actions |
14,600 |
$35.89 |
$523.99K |
- |
| 2024-05-18 |
Orbimed Advisors Llc |
Director |
OPA (Vente) |
264,315 |
$65.00 |
$17.18M |
- |
| 2024-05-18 |
Gold Mitchell |
Executive Chairman and CEO |
OPA (Vente) |
2,627,157 |
$65.00 |
$170.77M |
- |
| 2024-05-18 |
Topper James N |
Director |
OPA (Vente) |
2,829,347 |
$65.00 |
$183.91M |
- |
| 2024-05-18 |
Thompson Peter A. |
Director |
OPA (Vente) |
264,315 |
$65.00 |
$17.18M |
- |
| 2024-05-18 |
Cui Xiangmin |
10 Percent Owner |
OPA (Vente) |
1,735,544 |
$65.00 |
$112.81M |
- |
| 2024-05-08 |
Gold Mitchell |
Executive Chairman and CEO |
Exercice d'Options |
13,245 |
$7.55 |
$100K |
109,245 |
| 2024-05-08 |
Peng Stanford L |
See Remarks |
Exercice d'Options (Vente) |
161,492 |
$0.65 |
$104.97K |
- |
| 2024-05-08 |
Durand Remy |
Chief Business Officer |
Exercice d'Options (Vente) |
10,000 |
$4.76 |
$47.6K |
- |
| 2024-05-08 |
Fuhs Ulrich Martin |
Chief Accounting Officer |
Exercice d'Options |
22,820 |
$12.07 |
$275.44K |
30,120 |
| 2024-05-07 |
Rickey James Paul |
See Remarks |
Exercice d'Options (Vente) |
398 |
$5.02 |
$2K |
137 |
| 2024-04-25 |
Topper James N |
Director |
Exercice d'Options (ITM) |
1,200,000 |
$0.00 |
$1.2K |
- |
| 2024-04-03 |
Fuhs Ulrich Martin |
Chief Accounting Officer |
Cession |
14,600 |
$35.89 |
$523.99K |
- |
| 2024-01-26 |
Rickey James Paul |
See Remarks |
Vente Informative |
73,764 |
$22.31 |
$1.65M |
- |
| 2024-01-25 |
Rickey James Paul |
See Remarks |
Vente Informative |
236 |
$22.00 |
$5.19K |
- |
| 2024-01-18 |
Cui Xiangmin |
10 Percent Owner |
Exercice d'Options (ITM) |
1,234,636 |
$12.74 |
$15.73M |
- |
| 2024-01-18 |
Decheng Capital China Life Sciences Usd Fund Iii, L.p. |
10 Percent Owner |
Exercice d'Options (ITM) |
1,234,636 |
$12.74 |
$15.73M |
- |
| 2024-01-11 |
Orbimed Advisors Llc |
Director |
Exercice d'Options (ITM) |
145,251 |
$12.74 |
$1.85M |
- |
| 2024-01-11 |
Thompson Peter A. |
Director |
Exercice d'Options (ITM) |
145,251 |
$12.74 |
$1.85M |
- |
| 2024-01-04 |
Gold Mitchell |
Executive Chairman and CEO |
Attribution de RSU |
96,000 |
- |
- |
96,000 |
| 2024-01-04 |
Rickey James Paul |
See Remarks |
Attribution de RSU |
31,200 |
- |
- |
31,200 |
| 2024-01-04 |
Peng Stanford L |
See Remarks |
Attribution de RSU |
48,000 |
- |
- |
72,371 |
| 2024-01-04 |
Durand Remy |
Chief Business Officer |
Attribution de RSU |
31,200 |
- |
- |
38,104 |
| 2024-01-02 |
Conway Robert E |
Director |
Attribution de RSU |
17,500 |
$19.00 |
$332.5K |
17,500 |
| 2024-01-02 |
Topper James N |
Director |
Attribution de RSU |
17,500 |
$19.00 |
$332.5K |
17,500 |
| 2024-01-02 |
Thompson Peter A. |
Director |
Attribution de RSU |
17,500 |
$19.00 |
$332.5K |
17,500 |
| 2024-01-02 |
Cui Xiangmin |
10 Percent Owner |
Attribution de RSU |
17,500 |
$19.00 |
$332.5K |
17,500 |
| 2024-01-02 |
Peetz Christopher |
Director |
Attribution de RSU |
17,500 |
$19.00 |
$332.5K |
17,500 |
| 2024-01-02 |
Hernday Natasha |
Director |
Attribution de RSU |
17,500 |
$19.00 |
$332.5K |
17,500 |
| 2024-01-02 |
Drappa Jorn |
Director |
Attribution de RSU |
17,500 |
$19.00 |
$332.5K |
17,500 |
| 2023-12-28 |
Orbimed Advisors Llc |
Director |
Vente Informative |
139,166 |
$18.32 |
$2.55M |
264,315 |
| 2023-12-28 |
Gold Mitchell |
Executive Chairman and CEO |
Exercice d'Options (Vente) |
74,441 |
$12.74 |
$948.38K |
- |
| 2023-12-28 |
Thompson Peter A. |
Director |
Vente Informative |
139,166 |
$18.32 |
$2.55M |
264,315 |
| 2023-12-27 |
Gold Mitchell |
Executive Chairman and CEO |
Vente Informative |
29,573 |
$20.04 |
$592.72K |
- |
| 2023-12-27 |
Orbimed Advisors Llc |
Director |
Vente Informative |
18,922 |
$19.96 |
$377.68K |
406,609 |
| 2023-12-27 |
Thompson Peter A. |
Director |
Vente Informative |
18,922 |
$19.96 |
$377.68K |
406,609 |
| 2023-12-26 |
Gold Mitchell |
Executive Chairman and CEO |
Exercice d'Options (Vente) |
2,402 |
$0.45 |
$1.08K |
- |
| 2023-12-22 |
Gold Mitchell |
Executive Chairman and CEO |
Vente Informative |
37,825 |
$20.43 |
$772.59K |
- |
| 2023-12-19 |
Gold Mitchell |
Executive Chairman and CEO |
Vente Informative |
2,402 |
$20.01 |
$48.06K |
- |
■ Informatif — transaction sur marché ouvert (la plus significative)
■ Non informatif (achat) — récompense, exercice d'option, conversion
■ Non informatif (vente) — retenue fiscale, vente à l'acquisition
■ Neutre — don, fiducie, expiration
Les autres consultent aussi
